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Mutations in the SH3-domain binding protein 2 (SH3BP2) are known to cause a rare child-
hood disorder called cherubism that is characterized by inflammation and bone loss in 
the jaw, but the mechanism has remained unclear. In this issue, Ueki et al. (Ueki et al., 
2007) now demonstrate that a cherubism mutation activates mouse Sh3bp2 resulting in 
enhanced production of the cytokine TNF-α by myeloid cells, leading to both bone loss 
and inflammation.Cell 128, January 12, 2007 ©2007 Elsevier Inc. 15Cherubism is a dominantly inher-
ited disorder that is characterized 
by bone destruction in the upper 
and lower jaws and is accompanied 
by inflammation and fibrosis. The 
disease typically begins in children 
before the age of four and regresses 
at puberty. The cherubic appearance 
of children with the disorder, char-
acterized by an upward gaze and 
round face, stems from facial swell-
ing. Although the disease was first 
described in 1933, its pathogenesis 
has remained elusive. Genetic anal-
ysis has established several point 
mutations in the Sh3bp2 gene, which 
encodes a widely expressed scaf-
fold protein (Imai et al., 2003; Ueki et 
al., 2001). However, the function of 
this multidomain protein, the nature 
of the mutations (activating or domi-
nant-negative), and the primary cells 
involved in pathogenesis have been 
unclear. The disease is disfiguring 
during the active phase, and there 
are permanent dental complications. 
Although surgical intervention is 
sometimes successful, most patients 
do not receive any disease-modify-
ing treatment. Thus, the discovery by 
Ueki et al. (2007) that cherubism is 
caused by enhanced cytokine tumor 
necrosis factor α (TNF-α) production 
by myeloid cells due to an activating 
mutation in Sh3bp2 not only repre-
sents a major advancement in our 
understanding of the pathogenesis of the disease but suggests new poten-
tial options for its treatment.
Although the heritable nature of 
cherubism is well accepted, Ueki et 
al. are the first to establish an experi-
mental model of the disease, reca-
pitulating the most common human 
Sh3bp2 mutation (P418R) in mice. 
They created a knockin mouse model 
in which the disease causing proline 
to arginine substitution is introduced 
in the mouse Sh3bp2 gene (P416R). 
They find that there is inflammation 
and bone resorption in the jaw in mice 
homozygous for the mutation but also 
a global decrease in bone mass and 
systemic myeloid inflammation. Thus, 
although the model reproduces the 
classical phenotypes of cherubism, 
it is not restricted to the jaws and 
behaves primarily as an autosomal-
recessive disease, leaving open the 
possibility that additional factors 
contribute to the human disease.
The histology of affected tissue 
from cherubism patients is very simi-
lar to fibrous dysplasia (a disease 
involving cells of the mesenchymal 
lineage), with a mixture of fibrob-
lasts, bone-resorbing osteoclasts, 
and inflammatory cells. The course 
of cherubism is coincident with tooth 
eruption, and many patients fail to 
develop second and third molars. 
This has led to the proposal that 
cherubism is due to defective sign-
aling in mesenchymal cells associ-ated with tooth development, with 
enhanced activation of osteoclasts 
(the cells that resorb bone) as a 
secondary consequence (Hyckel et 
al., 2005). The issue of the patho-
genic cell has been resolved with 
the mutant Sh3bp2 knockin model. 
Myeloid osteoclast progenitors from 
mice bearing one or two mutant 
Sh3bp2 alleles formed more osteo-
clasts in culture, with higher resorp-
tive activity. Furthermore, inflamma-
tion and bone loss were transferred 
by bone marrow transplantation of 
mutant Sh3bp2 marrow into recipi-
ents with normal Sh3bp2, demon-
strating that the disease is caused 
by mutant Sh3bp2 in a hematopoietic 
cell. To further define the pathogenic 
cell type, the authors crossed the 
Sh3bp2 knockin mice with mice defi-
cient in rag1, which do not have func-
tional lymphocytes, and with op-defi-
cient mice, which lack myeloid cells. 
Mutant Sh3bp2 caused bone loss in 
the absence of lymphocytes but not 
in the absence of myeloid cells. Thus, 
the primary target for disease therapy 
should be the myeloid lineage.
Osteoclasts are multinucleated, 
terminally differentiated cells derived 
from the myeloid lineage, which 
degrade both the organic and mineral-
ized components of bone. The primary 
factor responsible for osteoclast differ-
entiation is RANKL, which signals via 
its receptor RANK and leads to acti-
Figure 1. Involvement of Mutant Sh3bp2 in Cherubism
Mutations in Sh3bp2 cause cherubism, which is characterized by inflammation and bone loss in the jaw. Sh3bp2 is a multidomain scaffolding 
protein with a pleckstrin-homology domain (PH), a proline-rich domain (Pro), and a Src-homology 2 domain (SH2). Most of the known cherubism 
mutations (CM) lie in a stretching region between the Pro and the SH2 domains. Downstream of stimulation by the cytokines M-CSF and RANKL, the 
Sh3bp2 P416R mutant (Sh3bp2*) regulates the formation of a complex containing a Src family kinase (SFK), Syk, PLCγ2, and Vav. In mice express-
ing Sh3bp2*, TNF production by osteoclast precursors is elevated in response to M-CSF via activation of the ERK signaling pathway. Sh3bp2* also 
leads to increased osteoclastogenesis via upregulation of the calcium-dependent gene NFATc1 downstream of RANKL and the costimulatory recep-
tors Dap12 and FcRγ that contain ITAMs (immunoreceptor tyrosine-based activation motifs). (Inset) In mice expressing Sh3pb2*, osteoclast precur-
sors express more TNF than wild-type mice leading to upregulation of M-CSF and RANKL by osteoblasts. The combination of M-CSF, RANKL, and 
TNF promotes the differentiation of osteoclast precursors and augments the bone-resporptive activity of mature osteoclasts.vation of NF-κB- and MAPK-depend-
ent pathways. However, costimulatory 
signals emanating from FcRγ or Dap12 
(transmembrane receptors harboring 
cytoplasmic immunoreceptor tyro-
sine-based activation motifs or ITAMs) 
are also required for osteoclastogen-
esis (Koga et al., 2004). RANKL-medi-
ated phosphorylation of ITAMs occurs 
via Src family kinases and results in 
the recruitment of Syk kinase (Mocsai 
et al., 2004), activation of phospholi-
pase Cγ2 (PLCγ2), and the mobiliza-
tion of intracellular Ca2+, which is criti-
cal for upregulation of NFAT-c1, the 
master transcription factor in osteo-
clasts (Mao et al., 2006). Interfer-
ing with any of the above molecules 
impairs the differentiation and func-
tion of osteoclasts. Sh3bp2 mediates 
ITAM-dependent activation of calcium 
signaling and NFATc1 upregulation in 
lymphocytes (Deckert et al., 1998). In 
these cells Sh3bp2 binds to Src fam-
ily kinases, Syk, PLC-γ, and Vav gua-
nosine exchange factors. Ueki and 
colleagues have now determined that 
the Sh3bp2 P416R cherubism muta-
tion in the osteoclast lineage leads to 
hyperphosphorylation of Syk at Y346 
and increases Syk activity in response 
to RANKL. Therefore, it is likely that 
Sh3bp2 also serves as an ITAM-
dependent scaffold in osteoclast pre-16 Cell 128, January 12, 2007 ©2007 Elscursors, bringing together Src family 
kinases, Syk, and PLCγ2 (Figure 1).
The myeloid progenitors of osteo-
clasts are also dependent on signal-
ing by macrophage colony-stimulat-
ing factor (M-CSF). Interestingly, the 
Sh3bp2 P416R mutation also leads 
to enhanced M-CSF signaling to 
the MAPK-ERK pathway. Consist-
ent with this observation, a recent 
report showed that activation of ERK 
and of its upstream kinase MEK1 was 
impaired in B cells from mice lacking 
Sh3bp2 (de la Fuente et al., 2006), 
possibly due to impaired Ras acti-
vation mediated by PLCγ2. Further 
work will be necessary to determine 
the exact pathways by which Sh3bp2 
mediates signaling downstream of 
M-CSF.
TNF-α potently activates osteo-
clasts and is responsible for a large 
proportion of bone loss in inflamma-
tory arthritis, periodontal disease, 
and prosthetic implant loosening. 
Therefore, it is perhaps surprising 
that the role of TNF-α in cherubism 
has not previously been explored. 
In the mutant Sh3bp2 knockin mice, 
increased levels of TNF-α in serum 
correlated with systemic inflammation 
and bone loss. When crossed onto a 
TNF-α null background, the mutant 
Sh3bp2 knockin mice no longer lose evier Inc.bone nor show evidence of inflam-
mation, demonstrating that TNF-α is 
required for these pathologies. Iso-
lated myeloid cells from the knockin 
mice produced large amounts of 
TNF-α in response to M-CSF treat-
ment (in an ERK-dependent manner), 
and transplantation of marrow from 
these same mice led to an elevation 
of serum TNF-α along with inflamma-
tion and bone loss. Thus, it appears 
that TNF-α generated by myeloid 
cells participates in a positive feed-
back loop, enhancing M-CSF and 
RANKL production by osteoblasts 
(Figure 1), which stimulates more 
TNF-α synthesis by the precursors. 
Acting on the precursors, the combi-
nation of M-CSF, RANKL, and TNF-α 
is potently osteoclastogenic (Kitaura 
et al., 2005), increasing the numbers 
of mature osteoclasts, which them-
selves are stimulated by the same set 
of cytokines for bone resorption.
Although cherubism was described 
more than 70 years ago, the rather 
sparse literature in this area has 
provided little insight on disease 
mechanisms or effective therapies. 
For patients with this rare disease, 
the identification of TNF-α as a major 
pathogenic factor is significant news. 
Anti-TNF therapies are already in clin-
ical practice for the treatment of rheu-
matoid arthritis. Should these drugs 
also prove effective in the treatment 
of cherubism it can be hoped that the 
interval from laboratory discovery to 
clinical use would be short.
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models can play an important role in 
integrating the wealth of information 
generated by molecular biology and 
genetics. They are particularly useful 
for understanding how phenomena 
at the tissue or organismal level arise 
from networks of molecular interac-
tions within and between cells. Ideally, 
such models should offer biological 
insight into complex phenomena and 
generate new testable hypotheses. 
The authors of two recent papers 
(Sick et al., 2006; Wang et al., 2006) 
appearing in Science and in the Pro-
ceedings of the National Academy of 
Sciences use contrasting approaches 
to model observed patterns of hair-
follicle distribution and orientation. 
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In one case the model is based on 
known and predicted properties of 
key signaling molecules, whereas 
the other model is more abstract and 
does not depend on specific biologi-
cal parameters.
Hair follicles are found in regular 
arrays in which large primary follicles 
that develop first are interspersed 
with smaller, secondary follicles that 
develop at a later stage. Both primary 
and secondary follicles are uniformly 
oriented in an anterior-posterior direc-
tion (Figure 1). Turing first proposed a 
reaction-diffusion (R-D) model that 
explained how amplification of small 
initial fluctuations of an activator and 
inhibitor that interact could lead to 
development of a spatial pattern of 
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morphogens (Turing, 1952). More 
recently, Jung et al. showed in skin 
explant cultures from chick embryos 
that the size, number, and distribution 
of developing feather buds could be 
altered by addition of specific morph-
ogens (Jung et al., 1998). Insight into 
the molecular signals that direct initial 
patterning of the hair-follicle array has 
been provided by experiments show-
ing that follicle induction is blocked 
by ectopic expression of Dickkopf1 
(Dkk1), a secreted Wnt/β-catenin 
inhibitor (Andl et al., 2002), and is 
stimulated by constitutive activation 
of the Wnt/β-catenin pathway (Gat 
et al., 1998; Kuraguchi et al., 2006). 
These observations identify Wnt/β-
catenin signaling as a key initiating 
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